Unique Advantages of Proplete Nutritional Supplement

Joe Cosgrove is the CEO of Pentec Health Incorporated, a specialty sterile compounding pharmacy providing services to patients in the home and other various alternate administration sites. The company is located in Boothwyn, Pennsylvania. Also the chairman of Pentec Health’s board, Joe Cosgrove manages the company’s development strategy and is largely responsible for its newest line of dietary supplements known as Proplete.

Due to its unique composition, Proplete, designed for those who experience problems after hemodialysis, provides benefits to patients with the following conditions:

Chronic Kidney Disease: An estimated 70 percent of patients with chronic kidney disease deal with malnutrition after receiving hemodialysis, which can lead to weight loss and low protein levels. Proplete provides significant doses of protein.
​​​​​​​
Fluid Management Problems: Patients with advanced cardiac or hepatic disease may experience problems with managing fluids. The low-volume nature of Proplete can help alleviate these concerns.

Obesity: Traditional hemodialysis medications often contain extra calories and lipids in addition to high levels of protein. Proplete contains no lipids and is low in carbohydrates, making it ideal for overweight or obese patients.

Diabetes: Many Intradialytic Parenteral Nutrition (IDPN) supplements require close supervision of blood glucose intake in diabetic patients. The low-dextrin formula of Proplete allows diabetic patients to more easily manage these levels.

Advertisements

Benefits of PROPLETE® for Dialysis Patients

Pentec Health pic

Pentec Health
Image: pentechealth.com

Joe Cosgrove serves as president, chairman, and CEO of Pentec Health, Inc., providers of the PROPLETE nutritional solution. Under Joe Cosgrove’s leadership, the launch of PROPLETE has been a significant factor in Pentec Health’s success.

An intradialytic parenteral nutrition (IDPN) solution, Pentec Health‘s PROPLETE addresses the particular nutritional needs of patients undergoing hemodialysis. This treatment significantly reduces the risk of protein deficiency, largely because the process of dialysis itself removes protein from the body at an above-average rate. Furthermore, kidney diseases, which dialysis aims to treat, affect the body’s ability to process amino acids into protein in the normal manner. These factors, combined with a predisposition toward loss of appetite, can cause a condition called protein-energy malnutrition (PEM).

Highly dangerous, PEM puts dialysis patients at increased risk of complications and even death. Statistically, patients with PEM present a much higher risk of death before the successful completion of trreatment. PROPLETE addresses this issue by introducing lipid-free, low-carbohydrate protein supplements into the patient’s body in sufficient amounts to compensate for dialysis-related protein loss. The compound also encourages the growth of protein and tissues in the body, thus combating both the risk and the potential effects of PEM.